The aim of this multicentric study was to define the clinical history of epilepsy and to clarify the efficacy of various antiepileptic drugs in patients with Rett Syndrome, using a questionnaire provived for each patient. In our sample of 89 patients, seizures at onset were partial or generalized in most cases. The most commonly used antiepileptic drugs were VPA, followed by CBZ and LTG. Drug resistance epilepsy occurred in 47% of cases. Some MECP2 mutations were most frequently associated with epilepsy than other ones. Nevertheless the prevalence of drug resistance epilepsy changed among different mutation type.
L'epilessia nella sindrome di Rett / M. Pintaudi, A. Vignoli, M.G. Baglietto, J. Hayek, F. La Briola, E. Parodi, F. Aiello, L. Giordano, J. Galli, E. Veneselli, M.P. Canevini. - In: BOLLETTINO-LEGA ITALIANA CONTRO L'EPILESSIA. - ISSN 0394-560X. - 2010:140(2010), pp. 100-101. ((Intervento presentato al 32. convegno Congresso Nazionale LICE tenutosi a Sorrento nel 2009.
L'epilessia nella sindrome di Rett
A. Vignoli;F. La Briola;M.P. Canevini
2010
Abstract
The aim of this multicentric study was to define the clinical history of epilepsy and to clarify the efficacy of various antiepileptic drugs in patients with Rett Syndrome, using a questionnaire provived for each patient. In our sample of 89 patients, seizures at onset were partial or generalized in most cases. The most commonly used antiepileptic drugs were VPA, followed by CBZ and LTG. Drug resistance epilepsy occurred in 47% of cases. Some MECP2 mutations were most frequently associated with epilepsy than other ones. Nevertheless the prevalence of drug resistance epilepsy changed among different mutation type.File | Dimensione | Formato | |
---|---|---|---|
Bollettino_140_ATTI_Sorrento.pdf
accesso solo dalla rete interna
Tipologia:
Publisher's version/PDF
Dimensione
69.4 MB
Formato
Adobe PDF
|
69.4 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.